Aisling R Caffrey

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 28

Top Topics

Urinary Tract Infection

Pseudomonas Aeruginosa

Multidrug Resistant

General Practice

Top Venues

Infectious diseases and therapy

Antibiotics (Basel, Switzerland)

Pharmacotherapy

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Kathryn Sine, Thomas Lavoie, Aisling R Caffrey, Vrishali V Lopes, David Dosa, Kerry L LaPlante, Haley J Appaneal
Exploring variations in recommended first-choice therapy for complicated urinary tract infections in males: Insights from outpatient settings across age, race, and ethnicity. Pharmacotherapy 44 (4) (2024)
Haley J Appaneal, Kerry L LaPlante, Vrishali V Lopes, Catherine Martin, Laura Puzniak, Timothy L Wiemken, Evan J Zasowski, John M McLaughlin, Aisling R Caffrey
Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System. Infectious diseases and therapy 13 (1) (2024)
Kathryn Sine, Thomas Lavoie, Aisling R Caffrey, Vrishali V Lopes, David Dosa, Kerry L LaPlante, Haley J Appaneal
Exploring variations in recommended first-choice therapy for complicated urinary tract infections in males: Insights from outpatient settings across age, race, and ethnicity. Pharmacotherapy (2024)
Haley J Appaneal, Kerry L LaPlante, Vrishali V Lopes, Catherine Martin, Laura Puzniak, Timothy L Wiemken, Evan J Zasowski, John M McLaughlin, Aisling R Caffrey
Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System. Infectious diseases and therapy 13 (1) (2024)
Kathryn Sine, Thomas Lavoie, Aisling R Caffrey, Vrishali V Lopes, David Dosa, Kerry L LaPlante, Haley J Appaneal
Exploring variations in recommended first-choice therapy for complicated urinary tract infections in males: Insights from outpatient settings across age, race, and ethnicity. Pharmacotherapy 44 (4) (2024)
Haley J Appaneal, Kerry L LaPlante, Vrishali V Lopes, Catherine Martin, Laura Puzniak, Timothy L Wiemken, Evan J Zasowski, John M McLaughlin, Aisling R Caffrey
Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System. Infectious diseases and therapy 13 (1) (2024)
Haley J Appaneal, Kerry L LaPlante, Vrishali V Lopes, Catherine Martin, Laura Puzniak, Timothy L Wiemken, Evan J Zasowski, John M McLaughlin, Aisling R Caffrey
Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System. Infectious diseases and therapy 13 (1) (2024)
Haley J Appaneal, Kerry L LaPlante, Vrishali V Lopes, Catherine Martin, Laura Puzniak, Timothy L Wiemken, Evan J Zasowski, John M McLaughlin, Aisling R Caffrey
Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System. Infectious diseases and therapy (2024)
Kathryn Sine, Thomas Lavoie, Aisling R Caffrey, Vrishali V Lopes, David Dosa, Kerry L LaPlante, Haley J Appaneal
Exploring variations in recommended first-choice therapy for complicated urinary tract infections in males: Insights from outpatient settings across age, race, and ethnicity. Pharmacotherapy 44 (4) (2024)
Haley J Appaneal, Aisling R Caffrey, Vrishali Lopes, David Dosa, Kerry L LaPlante
Antibiotic Prescribing in Outpatient Settings: Rural Patients Are More Likely to Receive Fluoroquinolones and Longer Antibiotic Courses. Antibiotics (Basel, Switzerland) 12 (2) (2023)
Haley J Appaneal, Aisling R Caffrey, Vrishali Lopes, David Dosa, Kerry L LaPlante
Antibiotic Prescribing in Outpatient Settings: Rural Patients Are More Likely to Receive Fluoroquinolones and Longer Antibiotic Courses. Antibiotics (Basel, Switzerland) 12 (2) (2023)
Dana M Gates, Steven A Cohen, Kelly Orr, Aisling R Caffrey
Demographic and Clinical Predictors of Pharmacist-Administered Pediatric Influenza Immunization. Journal of pharmacy practice (2023)
Haley J Appaneal, Aisling R Caffrey, Vrishali Lopes, David Dosa, Kerry L LaPlante
Antibiotic Prescribing in Outpatient Settings: Rural Patients Are More Likely to Receive Fluoroquinolones and Longer Antibiotic Courses. Antibiotics (Basel, Switzerland) 12 (2) (2023)
J Xin Liao, Haley J Appaneal, Anupama Menon, Vrishali Lopes, Kerry L LaPlante, Aisling R Caffrey
Decreasing Antibiotic Resistance Trends Nationally in Gram-Negative Bacteria Across United States Veterans Affairs Medical Centers, 2011-2020. Infectious diseases and therapy (2023)
Aisling R Caffrey, Haley J Appaneal, J Xin Liao, Emily C Piehl, Vrishali Lopes, Laura A Puzniak
Treatment Heterogeneity in Pseudomonas aeruginosa Pneumonia. Antibiotics (Basel, Switzerland) 11 (8) (2022)
Richard Tang, Vrishali L Lopes, Aisling R Caffrey
Colistin-associated Stevens-Johnson syndrome and toxic epidermal necrolysis reactions: a retrospective case-non-case pharmacovigilance study. Expert opinion on drug safety 21 (8) (2022)
Dana M Gates, Steven A Cohen, Kelly Orr, Aisling R Caffrey
Pharmacist-Administered Influenza Vaccination in Children and Corresponding Regulations. Vaccines 10 (9) (2022)
Haley J Appaneal, Aisling R Caffrey, Vrishali Lopes, Emily C Piehl, Laura A Puzniak, Kerry L LaPlante
Assessing Rates of Co-Resistance and Patient Outcomes in Multidrug-Resistant Pseudomonas aeruginosa. Microbiology spectrum 10 (5) (2022)
Haley J Appaneal, Vrishali V Lopes, Kerry L LaPlante, Aisling R Caffrey
Treatment, Clinical Outcomes, and Predictors of Mortality among a National Cohort of Admitted Patients with Acinetobacter baumannii Infection. Antimicrobial agents and chemotherapy 66 (3) (2022)
Aisling R Caffrey, Haley J Appaneal, Kerry L LaPlante, Vrishali V Lopes, Erlinda R Ulloa, Victor Nizet, George Sakoulas
Impact of Clopidogrel on Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: a National Retrospective Cohort Study. Antimicrobial agents and chemotherapy 66 (6) (2022)
Aisling R Caffrey, Haley J Appaneal, J Xin Liao, Emily C Piehl, Vrishali Lopes, Ryan J Dillon, Laura A Puzniak, Kerry L LaPlante
The Comparative Effectiveness of Ceftolozane/Tazobactam versus Aminoglycoside- or Polymyxin-Based Regimens in Multi-Drug-Resistant Pseudomonas aeruginosa Infections. Antibiotics (Basel, Switzerland) 11 (5) (2022)
Aisling R Caffrey, Eric P Borrelli
The art and science of drug titration. Therapeutic advances in drug safety 11 (2021)
Eric P Borrelli, Erica Y Lee, Aisling R Caffrey
Clozapine and hematologic adverse reactions: Impact of the Risk Evaluation and Mitigation Strategy program. The mental health clinician 10 (3) (2020)
Maya Beganovic, Jaclyn A Cusumano, Vrishali Lopes, Kerry L LaPlante, Aisling R Caffrey
Comparative Effectiveness of Exclusive Exposure to Nafcillin or Oxacillin, Cefazolin, Piperacillin/Tazobactam, and Fluoroquinolones Among a National Cohort of Veterans With Methicillin-Susceptible Staphylococcus aureus Bloodstream Infection. Open forum infectious diseases 6 (7) (2019)
Aisling R Caffrey, Tristan T Timbrook, Syed Raza Ali, Victor Nizet, George Sakoulas
Proton-pump inhibitors do not influence clinical outcomes in patients with Staphylococcus aureus bacteremia. Therapeutic advances in gastroenterology 12 (2019)
Aisling R Caffrey, Zachary R Babcock, Vrishali V Lopes, Tristan T Timbrook, Kerry L LaPlante
Heterogeneity in the treatment of bloodstream infections identified from antibiotic exposure mapping. Pharmacoepidemiology and drug safety 28 (5) (2019)
Ajinkya M Pawar, Kerry L LaPlante, Tristan T Timbrook, Aisling R Caffrey
Improved survival with continuation of statins in bacteremic patients. SAGE open medicine 6 (2018)
Eric P Borrelli, Erica Y Lee, Andrew M Descoteaux, Stephen J Kogut, Aisling R Caffrey
Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System. Epilepsia 59 (12) (2018)